The pharmaceutical sector has seen significant changes in the last two decades, including a shift toward biologics, patent expiration, and a significant reduction of big pharmaceuticals’ internal discovery.
The pharmaceutical sector has seen significant changes in the last two decades, including a shift toward biologics, patent expiration, and a significant reduction of big pharmaceuticals’ internal discovery.